MED12 (GeneName), Mediator of RNA polymerase II transcription subunit 12 (ProteinName), MED12_HUMAN.
Human MED12/ Mediator of RNA polymerase II transcription subunit 12 ELISA Kit
Activator-recruited cofactor 240 kDa component, ARC240, CAG repeat protein 45, Mediator complex subunit 12, OPA-containing protein, Thyroid hormone receptor-associated protein complex 230 kDa component, Trap230, Trinucleotide repeat-containing gene 11 protein, ARC240, CAGH45, HOPA, KIAA0192, TNRC11, TRAP230
Natural and recombinant human Mediator of RNA polymerase II transcription subunit 12
Serum, plasma, tissue homogenates, cell culture supernates and other biological fluids
Component of the Mediator complex, which is composed of MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a distinct module termed the CDK8 module. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP. Also interacts with CTNNB1 and GLI3.
Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway.
MAAFGILSYE | HRPLKRPRLG | PPDVYPQDPK | QKEDELTALN | VKQGFNNQPA |
VSGDEHGSAK | NVSFNPAKIS | SNFSSIIAEK | LRCNTLPDTG | RRKPQVNQKD |
NFWLVTARSQ | SAINTWFTDL | AGTKPLTQLA | KKVPIFSKKE | EVFGYLAKYT |
VPVMRAAWLI | KMTCAYYAAI | SETKVKKRHV | DPFMEWTQII | TKYLWEQLQK |
MAEYYRPGPA | GSGGCGSTIG | PLPHDVEVAI | RQWDYTEKLA | MFMFQDGMLD |
RHEFLTWVLE | CFEKIRPGED | ELLKLLLPLL | LRYSGEFVQS | AYLSRRLAYF |
CTRRLALQLD | GVSSHSSHVI | SAQSTSTLPT | TPAPQPPTSS | TPSTPFSDLL |
MCPQHRPLVF | GLSCILQTIL | LCCPSALVWH | YSLTDSRIKT | GSPLDHLPIA |
PSNLPMPEGN | SAFTQQVRAK | LREIEQQIKE | RGQAVEVRWS | FDKCQEATAG |
FTIGRVLHTL | EVLDSHSFER | SDFSNSLDSL | CNRIFGLGPS | KDGHEISSDD |
DAVVSLLCEW | AVSCKRSGRH | RAMVVAKLLE | KRQAEIEAER | CGESEAADEK |
GSIASGSLSA | PSAPIFQDVL | LQFLDTQAPM | LTDPRSESER | VEFFNLVLLF |
CELIRHDVFS | HNMYTCTLIS | RGDLAFGAPG | PRPPSPFDDP | ADDPEHKEAE |
GSSSSKLEDP | GLSESMDIDP | SSSVLFEDME | KPDFSLFSPT | MPCEGKGSPS |
PEKPDVEKEV | KPPPKEKIEG | TLGVLYDQPR | HVQYATHFPI | PQEESCSHEC |
NQRLVVLFGV | GKQRDDARHA | IKKITKDILK | VLNRKGTAET | DQLAPIVPLN |
PGDLTFLGGE | DGQKRRRNRP | EAFPTAEDIF | AKFQHLSHYD | QHQVTAQVSR |
NVLEQITSFA | LGMSYHLPLV | QHVQFIFDLM | EYSLSISGLI | DFAIQLLNEL |
SVVEAELLLK | SSDLVGSYTT | SLCLCIVAVL | RHYHACLILN | QDQMAQVFEG |
LCGVVKHGMN | RSDGSSAERC | ILAYLYDLYT | SCSHLKNKFG | ELFSDFCSKV |
KNTIYCNVEP | SESNMRWAPE | FMIDTLENPA | AHTFTYTGLG | KSLSENPANR |
YSFVCNALMH | VCVGHHDPDR | VNDIAILCAE | LTGYCKSLSA | EWLGVLKALC |
CSSNNGTCGF | NDLLCNVDVS | DLSFHDSLAT | FVAILIARQC | LLLEDLIRCA |
AIPSLLNAAC | SEQDSEPGAR | LTCRILLHLF | KTPQLNPCQS | DGNKPTVGIR |
SSCDRHLLAA | SQNRIVDGAV | FAVLKAVFVL | GDAELKGSGF | TVTGGTEELP |
EEEGGGGSGG | RRQGGRNISV | ETASLDVYAK | YVLRSICQQE | WVGERCLKSL |
CEDSNDLQDP | VLSSAQAQRL | MQLICYPHRL | LDNEDGENPQ | RQRIKRILQN |
LDQWTMRQSS | LELQLMIKQT | PNNEMNSLLE | NIAKATIEVF | QQSAETGSSS |
GSTASNMPSS | SKTKPVLSSL | ERSGVWLVAP | LIAKLPTSVQ | GHVLKAAGEE |
LEKGQHLGSS | SRKERDRQKQ | KSMSLLSQQP | FLSLVLTCLK | GQDEQREGLL |
TSLYSQVHQI | VNNWRDDQYL | DDCKPKQLMH | EALKLRLNLV | GGMFDTVQRS |
TQQTTEWAML | LLEIIISGTV | DMQSNNELFT | TVLDMLSVLI | NGTLAADMSS |
ISQGSMEENK | RAYMNLAKKL | QKELGERQSD | SLEKVRQLLP | LPKQTRDVIT |
CEPQGSLIDT | KGNKIAGFDS | IFKKEGLQVS | TKQKISPWDL | FEGLKPSAPL |
SWGWFGTVRV | DRRVARGEEQ | QRLLLYHTHL | RPRPRAYYLE | PLPLPPEDEE |
PPAPTLLEPE | KKAPEPPKTD | KPGAAPPSTE | ERKKKSTKGK | KRSQPATKTE |
DYGMGPGRSG | PYGVTVPPDL | LHHPNPGSIT | HLNYRQGSIG | LYTQNQPLPA |
GGPRVDPYRP | VRLPMQKLPT | RPTYPGVLPT | TMTGVMGLEP | SSYKTSVYRQ |
QQPAVPQGQR | LRQQLQQSQG | MLGQSSVHQM | TPSSSYGLQT | SQGYTPYVSH |
VGLQQHTGPA | GTMVPPSYSS | QPYQSTHPST | NPTLVDPTRH | LQQRPSGYVH |
QQAPTYGHGL | TSTQRFSHQT | LQQTPMISTM | TPMSAQGVQA | GVRSTAILPE |
QQQQQQQQQQ | QQQQQQQQQQ | QQQQQQYHIR | QQQQQQILRQ | QQQQQQQQQQ |
QQQQQQQQQQ | QQQQQHQQQQ | QQQAAPPQPQ | PQSQPQFQRQ | GLQQTQQQQQ |
TAALVRQLQQ | QLSNTQPQPS | TNIFGRY
This product has not yet been referenced specifically in any publications.
"A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome."
"The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene."
"No association of a dodecamer duplication in the human opposite paired (HOPA) gene with mental retardation and schizophrenia in Chinese patients from Taiwan."
"Association studies of the HOPA dodecamer duplication variant in different subtypes of autism."
"The association of a HOPA polymorphism with major depression and phobia."
"Population-based association analyses of the HOPA12bp polymorphism for schizophrenia and hypothyroidism."
"Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators."
"The genomic structure and developmental expression patterns of the human OPA-containing gene (HOPA)."
"cDNAs with long CAG trinucleotide repeats from human brain."
"Mutations in MED12 cause X-linked Ohdo syndrome."
Displaying results : 0
No feedback yet, let's comment.
Product Name *
Size Quantity Price ($) Subtotal 1 ($)
Subtotal 2: $
Size Quantity Price ($)
Do you want to be our agent and get a lower discount?
Please contact us:
Please contact us: